Skip to content
10-Q

Quarterly Report

Revolutions Medical CORP

0001437749-13-015016

← back to feed
Filed
Nov 19, 2013 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2013 · Nov 12, 2013 105.69M sh
Capex Q3 2013 · Sep 30, 2013 $992.91K
Operating Cash Flow Q3 2013 · Sep 30, 2013 −$14.28M
Operating Cash Flow restated Q3 2013 · Sep 30, 2012 −$1.65M
Total Liabilities Q3 2013 · Sep 30, 2013 $6.74M
Total Liabilities Q3 2013 · Dec 31, 2012 $4.41M
Current Assets Q3 2013 · Sep 30, 2013 $325.6K
Current Assets Q3 2013 · Dec 31, 2012 $326.7K
Total Assets Q3 2013 · Sep 30, 2013 $738.03K
Total Assets Q3 2013 · Dec 31, 2012 $790.05K
Sga Expense Q3 2013 · Sep 30, 2013 $29.44M
Sga Expense restated Q3 2013 · Sep 30, 2012 $952.95K
Sga Expense restated Q3 2013 · Sep 30, 2012 $3.36M
Rd Expense Q3 2013 · Sep 30, 2013 $2.94M
Rd Expense Q3 2013 · Sep 30, 2012 $9.9K
Rd Expense Q3 2013 · Sep 30, 2012 $99.59K
Net Income Q3 2013 · Sep 30, 2013 −$925.67K
Net Income Q3 2013 · Sep 30, 2013 −$41.99M
Net Income restated Q3 2013 · Sep 30, 2012 −$1.82M
Net Income restated Q3 2013 · Sep 30, 2012 −$5.18M
Operating Income Q3 2013 · Sep 30, 2013 −$39.48M
Operating Income restated Q3 2013 · Sep 30, 2012 −$1.3M
Operating Income restated Q3 2013 · Sep 30, 2012 −$3.84M
Gross Profit Q3 2013 · Sep 30, 2013 −$2.26M
Gross Profit restated Q3 2013 · Sep 30, 2012 −$313.31K
Gross Profit restated Q3 2013 · Sep 30, 2012 −$321.45K
Cost Of Revenue Q3 2013 · Sep 30, 2013 $11.84K
Cost Of Revenue Q3 2013 · Sep 30, 2012 $219
Cost Of Revenue Q3 2013 · Sep 30, 2012 $9.2K
Revenue Q3 2013 · Sep 30, 2013 $6.64K
Revenue Q3 2013 · Sep 30, 2012 $349
Revenue Q3 2013 · Sep 30, 2012 $1.19K
Stock Issued Q3 2013 · Dec 31, 2012 100K sh
Cash And Equivalents Q3 2013 · Sep 30, 2012 $1.07K
Cash And Equivalents Q3 2013 · Dec 31, 2011 $4.84K